Lactoferrin Versus Ferrous Fumarate for Treatment of Mild to Moderate Iron Deficiency Anemia During Pregnancy

• Status: Unknown status
• Trial end date: 2019-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study will conducted to evaluate and comparison between the effectiveness, safety and acceptability of lactoferrin alone, ferrous fumarate alone and combination of both for the treatment of mild to moderate IDA during pregnancy.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Assiut University
• Treatments: Ferrous fumarate; Iron; Lactoferrin

Criteria

Inclusion Criteria:

• Pregnant women from 24-36 weeks of gestation.

• Mild to moderate anemia.

Exclusion Criteria:

• Women with a history of anemia due to any other causes other than IDA.

• Severe anemia requiring blood transfusion.

• History of peptic ulcer.

• known hypersensitivity to iron preparations.